Alkem Laboratories Sees Notable Surge in Open Interest Amid Market Activity
2025-04-03 15:00:20Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 11,387 contracts, reflecting a rise of 1,369 contracts or 13.67% from the previous open interest of 10,018. The trading volume for the day reached 9,134 contracts, indicating robust activity in the derivatives market. In terms of price performance, Alkem Laboratories has underperformed its sector by 1.24%, despite gaining 1.84% over the last two days. The stock reached an intraday high of Rs 5,012.95, marking a 2.56% increase during the trading session. While the stock is currently above its 20-day and 50-day moving averages, it remains below its 5-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector overall has shown a gain of 2.15%, contrasting with Alkem's performance. Additionally, the stock's delive...
Read MoreAlkem Laboratories Sees Significant Rise in Open Interest Amid Market Activity
2025-04-03 14:00:23Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a notable increase in open interest today. The latest open interest stands at 11,387 contracts, reflecting a rise of 1,369 contracts or 13.67% from the previous open interest of 10,018. The trading volume for the day reached 9,134 contracts, indicating active participation in the market. In terms of price performance, Alkem Laboratories has underperformed its sector by 1.27%, despite gaining 2.04% over the last two days. The stock reached an intraday high of Rs 5,012.95, marking a 2.56% increase during the session. While the stock is currently above its 20-day and 50-day moving averages, it remains below the 5-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector overall has seen a gain of 2.22%. However, Alkem's delivery volume has decreased by 19.95% compared to its 5-day average, in...
Read MoreAlkem Laboratories Sees Significant Rise in Open Interest Amid Market Activity
2025-04-03 13:00:16Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a notable increase in open interest today. The latest open interest stands at 11,326 contracts, reflecting a rise of 1,308 contracts or 13.06% from the previous open interest of 10,018. The trading volume for the day reached 7,990 contracts, indicating active participation in the market. In terms of price performance, Alkem Laboratories has underperformed its sector by 1.45%, despite gaining 1.91% over the last two days. The stock reached an intraday high of Rs 5,012.95, marking a 2.56% increase during the session. While the stock is currently above its 20-day and 50-day moving averages, it remains below the 5-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector overall has seen a gain of 2.09%, contrasting with Alkem's performance. Additionally, delivery volume has decreased by 19.95...
Read MoreSurge in Open Interest for Alkem Laboratories Signals Increased Trading Activity Amid Mixed Performance
2025-04-03 12:00:20Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a notable increase in open interest today. The latest open interest stands at 11,326 contracts, reflecting a rise of 1,308 contracts or 13.06% from the previous open interest of 10,018. The trading volume for the day reached 7,990, indicating active participation in the stock. In terms of price performance, Alkem Laboratories has underperformed its sector by 1.54%, despite gaining 2.03% over the last two days. The stock reached an intraday high of Rs 5,012.95, marking a 2.56% increase during the session. While the stock is currently above its 20-day and 50-day moving averages, it remains below the 5-day, 100-day, and 200-day moving averages. The Pharmaceuticals & Drugs sector overall has seen a gain of 2.51%. However, Alkem's delivery volume has decreased by 19.95% compared to its 5-day average, with a delive...
Read MoreAlkem Laboratories Faces Mixed Technical Trends Amid Market Fluctuations
2025-04-03 08:05:40Alkem Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 4,907.95, showing a notable increase from the previous close of 4,833.80. Over the past year, Alkem has experienced fluctuations, with a 52-week high of 6,440.00 and a low of 4,409.90. The technical summary indicates a mixed performance across various indicators. The MACD shows bearish tendencies on a weekly basis, while the monthly outlook is mildly bearish. The Bollinger Bands and KST also reflect a mildly bearish stance, suggesting a cautious market sentiment. Conversely, the Dow Theory indicates a mildly bullish trend on a weekly basis, highlighting some positive momentum. In terms of returns, Alkem's performance has varied significantly. Over the past week, the stock returned -1.81%, underperforming the Sen...
Read MoreSurge in Open Interest Signals Shift in Market Dynamics for Alkem Laboratories
2025-03-25 15:01:04Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 16,103 contracts, reflecting a rise of 2,552 contracts or 18.83% from the previous open interest of 13,551. This surge in open interest comes alongside a trading volume of 11,560 contracts, indicating heightened activity in the derivatives market. In terms of price performance, Alkem Laboratories has outperformed its sector by 0.54%. However, the stock has seen a trend reversal, falling after four consecutive days of gains. The stock touched an intraday low of Rs 4,938.8, marking a decline of 2.25%. The weighted average price suggests that more volume was traded closer to this low price point. Despite the recent decline, Alkem Laboratories remains above its 5-day, 20-day, and 50-day moving averages, although it is below the 100-...
Read MoreAlkem Laboratories Sees Significant Surge in Open Interest Amid Market Activity
2025-03-25 14:00:45Alkem Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 16,007 contracts, reflecting a rise of 2,456 contracts or 18.12% from the previous open interest of 13,551. The trading volume for the day reached 9,308 contracts, indicating robust activity in the derivatives market. In terms of price performance, Alkem Laboratories has shown a slight decline, with the stock trading at an intraday low of Rs 4,938.8, down 2.25%. The stock's performance today aligns closely with the sector, which recorded a 1.28% decline. Despite this drop, the stock remains above its 5-day, 20-day, and 50-day moving averages, although it is below the 100-day and 200-day moving averages. Investor participation has seen a decrease, with delivery volume falling by 19.03% compared to the 5-day average. The stock's l...
Read MoreAlkem Laboratories Faces Technical Trend Shifts Amidst Market Evaluation Adjustments
2025-03-24 08:02:32Alkem Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5000.95, showing a notable increase from the previous close of 4896.75. Over the past year, Alkem has experienced a stock return of 4.22%, which is slightly below the Sensex return of 5.87% during the same period. In terms of technical indicators, the weekly MACD and KST are showing bearish trends, while the monthly indicators reflect a mildly bearish sentiment. The Bollinger Bands indicate a mildly bearish trend on a weekly basis, with a sideways movement observed monthly. The daily moving averages also suggest a mildly bearish outlook, while the Dow Theory indicates a mildly bullish trend on a weekly basis. When comparing the company's performance to the Sensex, Alkem has shown a strong return of 42.83% over t...
Read More
Alkem Laboratories Shows Trend Reversal Amid Broader Market Gains and Mixed Signals
2025-03-17 15:35:23Alkem Laboratories experienced a notable performance on March 17, 2025, reversing a two-day decline and outperforming its sector. The stock reached a high during intraday trading and is currently above its short-term moving averages, while the broader market saw gains in mid-cap stocks and the Sensex.
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
31-Mar-2025 | Source : BSEThis is to inform you that Mr. Adil Billimoria Senior Management Personnel of the Company shall retire from the Company with effect from closing of business hours of 31st March 2025.
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
28-Mar-2025 | Source : BSEPursuant to Regulation 30 of SEBI LODR Regulations 2015 this is to inform you that the Company has received orders passed by the statutory authority under the Goods and Services Tax Act 2017. The relevant disclosure is enclosed herewith.
Announcement under Regulation 30 (LODR)-Updates on Acquisition
28-Mar-2025 | Source : BSEIn continuation of our earlier intimation dated 07th February 2025 we wish to inform you that today i.e. 28th March 2025 a share purchase agreement has been executed inter alios amongst the Company and Adroit.
Corporate Actions
No Upcoming Board Meetings
Alkem Laboratories Ltd has declared 1850% dividend, ex-date: 14 Feb 25
No Splits history available
No Bonus history available
No Rights history available